Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages.

Pham, Haithuy; Medford, Whitney Gibson; Horst, Spencer; Levesque, Melissa; Ragoonanan, David; Price, Christine; Colbassani, Harold; Piper, Keaton; Chastain, Keith

Pham, Haithuy; Medford, Whitney Gibson; Horst, Spencer; Levesque, Melissa; Ragoonanan, David; Price, Christine; Colbassani, Harold; Piper, Keaton; Chastain, Keith.

Afiliación

Pham H; Memorial Regional Hospital, 3501 Johnson Street, Hollywood, FL 33021, United States of America. Electronic address: hpham@mhs.net.
Medford WG; Tampa General Hospital, 1 Tampa General Cir, Tampa, FL 33606, United States of America; BayCare Health System Virtual ICU, 900 Carillon Parkway Suite 402b, St. Petersburg, FL 33716, United States of America.
Horst S; St. Anthony's Hospital, 1200 7th Ave N, St. Petersburg, FL 33705, United States of America.
Levesque M; Tampa General Hospital, 1 Tampa General Cir, Tampa, FL 33606, United States of America.
Ragoonanan D; Tampa General Hospital, 1 Tampa General Cir, Tampa, FL 33606, United States of America.
Price C; Morton Plant Hospital, 300 Pinellas St, Clearwater, FL 33756, United States of America.
Colbassani H; Morton Plant Hospital, 300 Pinellas St, Clearwater, FL 33756, United States of America.
Piper K; Tampa General Hospital, 1 Tampa General Cir, Tampa, FL 33606, United States of America.
Chastain K; BayCare Health System, 2985 Drew St., Clearwater, FL 33759, United States of America.

Am J Emerg Med ; 55: 38-44, 2022 05.

Article en En | MEDLINE | ID: mdl-35272069

Asunto(s)

Rivaroxabán; Tromboembolia; Anticoagulantes/efectos adversos; Factores de Coagulación Sanguínea/farmacología; Factores de Coagulación Sanguínea/uso terapéutico; Hemorragia Cerebral; Factor Xa; Inhibidores del Factor Xa/efectos adversos; Humanos; Hemorragias Intracraneales/inducido químicamente; Hemorragias Intracraneales/tratamiento farmacológico; Pirazoles; Piridonas; Proteínas Recombinantes; Estudios Retrospectivos; Rivaroxabán/efectos adversos

Palabras clave

Antidotes; Apixaban; Cerebral hemorrhage; Direct factor Xa inhibitor; Direct-acting oral anticoagulant; Factor Xa inhibitor; Hemostasis; Intracranial hemorrhages; Prothrombin complex concentrate; Rivaroxaban

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tromboembolia / Rivaroxabán Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Emerg Med Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google